Evidence map›Paper›PMID 42848278›Full record

ReviewMolecular biology reports2026

Oncobiome relation with HPV and Gynecological cancer.

Saman Soleimanpour, Atieh Yaghoubi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Saman SoleimanpourAntimicrobial Resistance Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran.
Atieh YaghoubiAntimicrobial Resistance Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran. YaghoubiAT@mums.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

By now, it is well understood that the human body is inhabited by millions of tiny organisms that are alive and found in different parts of our body that called microbiota. Over the past decades, these tiny microorganisms have worked together like a smart network that links to human health, and any alterations or dysbiosis in this network lead to different disorders as well as cancer development. Hence, many preclinical and clinical studies have focused on clarifying the exact role of microflora in cancer development. One of these cancers is gynecological cancer, which is considered a major threat to health in the female population. In the case of gynecological malignancy, the presence and persistent infection with human papillomavirus (HPV) is also important. Persistent infection with HPV leads to alterations in the commensal population of microbiota in the vagina and even the gut, resulting in cancer progression. Therefore, we aimed to comprehensively review the current knowledge on the interaction between gut microbiota and vaginal microbiota in HPV acquisition, favoring gynecological cancer development.

Indexed as

Genital Neoplasms, FemaleHuman Papillomavirus VirusesPapillomavirus InfectionsAnimalsDysbiosisFemaleGastrointestinal MicrobiomeHumansMicrobiotaPapillomaviridaeVaginaCervical cancerDysbiosisEndometrial cancerGynecological cancersHPVMicrobiotaOncobiomeOvarian cancer

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.